Qualigen Therapeutics, Inc. Reports Year-End 2021 Financial Results
Go back to Qualigen Therapeutics, Inc. Reports Year-End 2021 Financial Results| (NASDAQ: QLGN) | Delayed: 3.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.21 | 52 Week High | $ | |||
| Open | $3.21 | 52 Week Low | $ | |||
| Day High | $3.21 | P/E | N/A | |||
| Day Low | $3.21 | EPS | $ | |||
| Volume | 14,490 | |||||

